Similar Stories to Covid-19 Vaccine Must Protect 50% Of People For Approval, Fda Says on Bing News

Enlarge / Stephen Hahn, Commissioner of Food and Drugs at the US Food and Drug Administration (FDA), speaks during a Senate Health, Education, Labor and Pensions Committee hearing on June 30, 2020, in Washington, DC. (credit: Getty | Al Drago) Any experimental COVID-19 vaccines aspiring to earn regulatory approval from the Food and Drug Administration will need to prevent or decrease the severity of disease in at least 50 percent of people, the agency announced Tuesday. The criterium is part of a larger set of guidelines released by the agency for developing a vaccine to halt the spread of pandemic coronavirus, SARS-CoV-2—which causes COVID-19 and is now accelerating in much of the country after months of sustained devastation. With the guidelines, the FDA tried to dispel fears that the rush to develop a COVID-19 vaccine may come at the expense of adequate safety testing.

BING NEWS:
  • Another COVID vaccine? Yes, and here’s why
    The shot targets a new version of the virus, advisers say. It bolsters your body’s defense system. And it’s a lot better than getting very sick or hospitalized.
    06/12/2024 - 4:40 am | View Link
  • What to know about Moderna’s combination COVID, flu vaccine
    An upcoming combination COVID-19 and flu vaccine was found to be more effective than the existing standalone vaccines.
    06/11/2024 - 12:51 pm | View Link
  • How Anti-Vaccine Kooks And Quacks Lie To You
    However, rampant anti-vaccine ... people—unlike most other drugs and medical devices—they are among the most exhaustively studied medical interventions. Extensive clinical trials test vaccines for ...
    06/10/2024 - 8:25 pm | View Link
  • Moderna says COVID-19/flu combo vaccine superior to separate shots in trial
    Moderna said on Monday its combination vaccine to protect against both COVID-19 and influenza generated ... The latest data was collected from two arms of a larger study that involved around 8,000 ...
    06/10/2024 - 12:29 pm | View Link
  • Combo COVID/flu vaccine elicits higher immune response in trial
    Advertisement The phase 3 trial is only another step towards approval of the dual-purpose ... that neither the patients nor the people conducting the trial knew who got which vaccines. Moderna added ...
    06/10/2024 - 1:33 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News